期刊文献+

人乳低聚糖研究进展 被引量:3

Human Milk Oligosaccharides:Past Achievements and Current Trends
下载PDF
导出
摘要 随着人们对人乳低聚糖(human milk oligosaccharides,HMOs)分布、有益生物活性,特别是调节人体肠道菌群益生元活性的认识日益深入,HMOs的相关研究越来越受到重视。然而,HMOs的应用通常是困难的,挑战在于适用于婴幼儿配方乳粉HMOs的特殊选择和天然来源中有限的HMOs含量,特殊HMOs应用的困难在于对于特定HMOs含量及其对儿童健康影响的研究很少。本文综述母乳中复杂的HMOs成分、可能的产品来源、功能和安全问题等方面的研究现状,重点综述HMOs成分、HMOs来源、HMOs生物活性的最新研究进展及未来研究方向。 With increasing knowledge about the distribution and beneficial bioactivities of human milk oligosaccharides(HMOs),especially prebiotic activities that modulate the human gut microbiota,HMOs have received growing research attention.However,the application of HMOs is generally difficult.The challenges are the special selection of suitable HMOs for infant formula and the limited amount of HMOs from natural sources.In the literature,there are few studies on the content of special HMOs and their impact on infant health outcomes.In this article,the current status of research on the complex composition,possible sources,functions and safety of HMOs are summarized with focus on the state-of-the-art in these regards.Finally,an outlook on future research directions is given.
作者 揭良 苏米亚 贾宏信 陈文亮 齐晓彦 JIE Liang;SU Miya;JIA Hongxin;CHEN Wenliang;QI Xiaoyan(Shanghai Engineering Research Center of Dairy Biotechnology,State Key Laboratory of Dairy Biotechnology,Dairy Research Institute,Bright Dairy and Food Co.Ltd.,Shanghai 200436,China)
出处 《乳业科学与技术》 2020年第5期31-36,共6页 JOURNAL OF DAIRY SCIENCE AND TECHNOLOGY
基金 “十三五”国家重点研发计划重点专项(2018YFC1604205) 上海市科学技术委员会科研计划项目(17391901100) 上海乳业生物工程技术研究中心项目(19DZ2281400)。
关键词 母乳 低聚糖 婴儿配方乳粉 human milk oligosaccharides infant formula
  • 相关文献

参考文献2

二级参考文献20

  • 1《特殊医学用途配方食品通则征求意见稿》,2012,中华人民共和国卫生部.
  • 2殷继永,黄建,霍军生.特殊膳食用食品膳食补充剂全球概况[N].中国食品报,2009-02-13:8.
  • 3American Academy of Pediatrics, Committee on Nutrition (美国儿科学会营养委员会). Reimbursement for foods for special dietary rose [J]. American Academy of Pediatrics, 2003,111 ( 5 ) : 1117- 1119.
  • 4Hata Y, Kakajima K. Studies of relationship betweenintake of fructooligosaccharides and abdominal symptoms:estimation of the-maximumnon-effective dose and 50% laxative effect dose [J]. Geriatr Med,1985 (23) :817.
  • 5Tokunaga T, Nakada Y, Tashiro Y, Hirayama M, Hidaka H. Effects of fructooligosaccharides ( FOS ) intake on the intestinal microflora and defecation in healthy volunteers [J]. Bifidus Flores, Fructuset Semina, 1993, 6 : 143.
  • 6Ramakrishna B S, Mathan, V I. Colonic dysfunction inacute diarrhoea: The role of luminal short chain fatty acids [J]. Gut 1993, 34:1215.
  • 7Bowling T E, Raimundo A H, Silk D B. Colonicsecretory effect in responseto enteral feeding in man [J]. Gut 1993, 34 (Suppl. 1 ) :33.
  • 8Younes H, Garleb K A, Behr,S. Fermentable fibers or oligosac- charides reduced urinarynitrogen excretion by increasing urea disposal in the ratcecum [ J]. Nutr,1995, 125:1010.
  • 9Bourquin L D, Bennink M R, Rozeboom K A, Wolf B. Fructooligosaccharides (FOS) enhance cecal andcolonic development of neonatal pigs [J]. FASEB J,1997, 11 :A601.
  • 10Breuer R I, Bjio S K, Christ M L, Bean J, Vemia A P, Paoluzi P, DiPaolo M C, Caprilli R. Rectalirrigation with short-chain fatty acids for distal ulcerativecolitis (preliminary report) [ J ]. Dig Dis Sci,1991, 36:185.

共引文献30

同被引文献31

引证文献3

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部